|
Multiple Sclerosis/ Demyelinating Disease
Citations 141-150 of 328 total displayed.
|
Past content
(since Jan 1998):
|
- Original Contributions
Multifocal Visual Evoked Potential Latency Analysis: Predicting Progression to Multiple Sclerosis
- Clare Fraser; Alexander Klistorner; Stuart Graham; Raymond Garrick; Francis Billson; John Grigg
Arch Neurol 2006; 63: 847-850.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Interleukin 23 in Acute Inflammatory Demyelination of the Peripheral Nerve
- Wei Hu; Thomas Dehmel; Jaana Pirhonen; Hans-Peter Hartung; Bernd C. Kieseier
Arch Neurol 2006; 63: 858-864.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Magnetization Transfer Magnetic Resonance Imaging and Clinical Changes in Patients With Relapsing-Remitting Multiple Sclerosis
- Celia Oreja-Guevara; Arnaud Charil; Domenico Caputo; Rosella Cavarretta; Maria Pia Sormani; Massimo Filippi
Arch Neurol 2006; 63: 736-740.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Epstein-Barr Virus and Multiple Sclerosis: Evidence of Association From a Prospective Study With Long-term Follow-up
- Gerald N. DeLorenze; Kassandra L. Munger; Evelyn T. Lennette; Norman Orentreich; Joseph H. Vogelman; Alberto Ascherio
Arch Neurol 63.6.noc50328.
[Abstract]
[Full text]
[]
- Original Contributions
Correlation of Global N-Acetyl Aspartate With Cognitive Impairment in Multiple Sclerosis
- Henrik Kahr Mathiesen; Agnete Jonsson; Thomas Tscherning; Lars G. Hanson; Jente Andresen; Morten Blinkenberg; Olaf B. Paulson; Per Soelberg Sorensen
Arch Neurol 2006; 63: 533-536.
[Abstract]
[Full text]
[PDF]
- Controversies in Neurology
Not Every Patient With Multiple Sclerosis Should Be Treated at Time of Diagnosis
- Sean J. Pittock; Brian G. Weinshenker; John H. Noseworthy; Claudia F. Lucchinetti; Mark Keegan; Dean M. Wingerchuk; Jonathan Carter; Elizabeth Shuster; Moses Rodriguez
Arch Neurol 2006; 63: 611-614.
[Extract]
[Full text]
[PDF]
- Controversies in Neurology
Most Patients With Multiple Sclerosis or a Clinically Isolated Demyelinating Syndrome Should Be Treated at the Time of Diagnosis
- E. M. Frohman; E. Havrdova; F. Lublin; F. Barkhof; A. Achiron; M. K. Sharief; O. Stuve; M. K. Racke; L. Steinman; H. Weiner; M. Olek; R. Zivadinov; J. Corboy; C. Raine; G. Cutter; J. Richert; M. Filippi
Arch Neurol 2006; 63: 614-619.
[Extract]
[Full text]
[PDF]
- Controversies in Neurology
Early Multiple Sclerosis: To Treat or Not to Treat?
- E. S. Roach
Arch Neurol 2006; 63: 619.
[Extract]
[Full text]
[PDF]
- Correspondence
Interferon Beta-1a Treatment and African Americans
- Fredric K. Cantor
Arch Neurol 2006; 63: 627-b-628-b.
[Extract]
[Full text]
[PDF]
- Correspondence
Interferon Beta-1a Treatment and African Americans—Reply
- Bruce A. C. Cree
Arch Neurol 2006; 63: 628.
[Extract]
[Full text]
[PDF]
|
|
